pretickt

Is MRSH a good stock to buy?

Marsh & McLennan Companies, Inc. · end-of-day data as of Nov 13, 2026

Marsh McLennan
MRSH · $99.15B
$207.78+1.0%
Nov 13, 2026 · close
$180$200SepOctNov9:3016:003 months +12.1%Nov 13 · close
▲ 4
  • FCF yield+4.2%
  • Trendbullish
  • MAs4 of 4
  • Sector▲ -1.8%
Neutral
  • Earnings in76d
  • P/E24.9x
  • RSI66
  • Support-1.3%
  • Resistance+3.0%
  • Off 52w high-2.9%
  • Volume0.8x
  • Bollingerupper half
  • News0.00
  • ConsensusHold · 24
  • 52w range$157–$214
  • ATR+2.2%
  • Off ATH-16.2%
▼ 5
  • PT$207.50 -0.1%
  • P/E vs own+17.7%
  • P/E vs sector+71.2%
  • Insiders-$4.6M
  • MACD-0.03

Updates with the 15-min delayed price. Not a forecast or investment advice.

Is Marsh McLennan a good stock to buy?

Marsh McLennan is strong on 3 of the 4 questions about the business. The price is about usual: 24.9 times its earnings, near its 3-year median of 25.6 (Nov 13, 2026). pretickt does not say whether to buy or sell.

  1. Demand growing
  2. Economics very profitable
  3. Execution delivers
  4. Fragility some risks
  5. Price about usual
DemandDo people want more of what it sells?growing

MRSH sales growth revenue growth

+9%a year, for the last 3 years

Marsh McLennan's sales grew 9% a year for 3 years, to $26.98B in fiscal 2025.

MRSH analysts' forecast revenue estimates

+7%the sales they expect next fiscal year, on the last

Analysts expect Marsh McLennan's sales to grow 7% to $28.76B in fiscal 2026 (14 analysts).

MRSH competitors

pretickt analysis+8%its sales in 12 months, on a year before

Marsh McLennan's sales grew 8% in the 12 months to Sep 30, 2026, faster than Willis Towers Watson (+5%) and Aon (+4%), slower than Brown & Brown (+31%) and Arthur J. Gallagher (+26%).

EconomicsDoes it make good money?very profitable

MRSH margin after costs profit margin

21%of sales left after running the business

Marsh McLennan's operating margin was 21% in the 12 months to Sep 30, 2026, against 21% in fiscal 2022.

MRSH cash generated free cash flow

$4.15Bcash left after investing, last 12 months

Marsh McLennan generated $4.15B of free cash flow in the 12 months to Sep 30, 2026, about as much as its reported profit.

MRSH profit per share

+3%in its last fiscal year

Marsh McLennan's earnings per share grew 3% in fiscal 2025, to $8.43.

ExecutionDoes it deliver what it promises?delivers

MRSH earnings vs estimates

8 of 8quarters above the analysts' estimate

Marsh McLennan beat the analysts' profit estimate in each of its last 8 quarters, the latest on Oct 15, 2026.

MRSH insider selling

-$17.45Msold, net, by its executives in 12 months

Marsh McLennan's executives and directors sold a net $17.45M of shares in the 12 months to Nov 13, 2026; none bought.

MRSH number of employees

+6%more people in a year

Marsh McLennan had 95,000 employees at the end of fiscal 2025, 6% more than a year before.

Fragility risksCould something break it?some risks

MRSH in past recessions

pretickt analysis-8%its sales in the worst one

Marsh McLennan's sales fell in 1 of the last 2 US recessions, by as much as 8% in fiscal 2009.

Price valuationIs the price reasonable?about usual

MRSH price vs profit P/E ratio

24.9×a year's earnings

Marsh McLennan's P/E ratio is 24.9 (Nov 13, 2026), near its 3-year median of 25.6.

MRSH price vs assets price to book

6.8×times what its assets are worth on paper

Marsh McLennan trades at 6.8 times its book value (Nov 13, 2026); its competitors' median is 3.5.

MRSH price vs competitors

pretickt analysis24.9×a year's earnings, against its competitors

Investors pay 24.9 times Marsh McLennan's earnings (Nov 13, 2026), more than for Brown & Brown (21.3), Willis Towers Watson (20.5) and Aon (18.5), less than for Arthur J. Gallagher (43.3).

MRSH analysts' target price target

0%to their average target

Analysts' average price target for Marsh McLennan is $208, 0% below the Nov 13, 2026 close of $207.78.

MRSH analyst ratings, 90 days

pretickt analysis
  • BMO Capitalupgrade
1 up, 0 downratings raised and cut

In the 90 days to Nov 13, 2026, BMO Capital upgraded Marsh McLennan.

MRSH growth priced in fair value

pretickt analysis+9%a year, for ten years, to be worth the price

At $207.78 a share, Marsh McLennan's free cash flow must grow about 9% a year for ten years to be worth the price (Nov 13, 2026).

What is Marsh McLennan's P/E ratio?

Marsh McLennan's P/E ratio is 24.9 (Nov 13, 2026), near its 3-year median of 25.6. Investors pay 24.9 times Marsh McLennan's earnings (Nov 13, 2026), more than for Brown & Brown (21.3), Willis Towers Watson (20.5) and Aon (18.5), less than for Arthur J. Gallagher (43.3).

Who are Marsh McLennan's biggest competitors?

pretickt compares Marsh McLennan with Arthur J. Gallagher, Aon, Willis Towers Watson and Brown & Brown. Marsh McLennan's sales grew 8% in the 12 months to Sep 30, 2026, faster than Willis Towers Watson (+5%) and Aon (+4%), slower than Brown & Brown (+31%) and Arthur J. Gallagher (+26%).

Is Marsh McLennan profitable?

Marsh McLennan's operating margin was 21% in the 12 months to Sep 30, 2026, against 21% in fiscal 2022. Marsh McLennan generated $4.15B of free cash flow in the 12 months to Sep 30, 2026, about as much as its reported profit.

Are insiders selling Marsh McLennan stock?

Marsh McLennan's executives and directors sold a net $17.45M of shares in the 12 months to Nov 13, 2026; none bought.

How many employees does Marsh McLennan have?

Marsh McLennan had 95,000 employees at the end of fiscal 2025, 6% more than a year before.

From the companies' statements (FMP), their filings read by pretickt, the analysts and the insiders, as of Nov 13, 2026. Each card says what a fact means for its question, never what to do with the stock: for information only, not investment advice.